Provided by Tiger Trade Technology Pte. Ltd.

Vertex Pharmaceuticals

506.74
-16.0700-3.07%
Post-market: 508.762.02+0.40%19:52 EDT
Volume:1.19M
Turnover:607.60M
Market Cap:128.57B
PE:29.49
High:523.52
Open:522.39
Low:505.27
Close:522.81
52wk High:560.25
52wk Low:392.50
Shares:253.72M
Float Shares:253.72M
Volume Ratio:1.37
T/O Rate:0.47%
Dividend:- -
Dividend Rate:- -
EPS(TTM):17.18
EPS(LYR):15.32
ROE:23.54%
ROA:11.93%
PB:6.35
PE(LYR):33.08

Loading ...

Vertex Minerals Revises Timeline for Proposed Securities Issue

TIPRANKS
·
Sep 14

Vertex Pharmaceuticals Price Target Raised to $560.00/Share from $515.00 by JP Morgan

Dow Jones
·
Sep 11

Vertex Minerals Confirms Reward Gold Mine Resource After ASX‑Driven Update

TIPRANKS
·
Sep 11

Vertex Pharmaceuticals Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Sep 11

Vertex Pharma EVP Jasper Van Grunsven Files Initial Beneficial Ownership Statement

Reuters
·
Sep 11

Vertex Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 09

Vertex Pharmaceuticals Inc Stock (VRTX) Moved Down by 3.06% on Sep 8: What Signal Does It Send?

TradingKey
·
Sep 09

Movement Alert|Vertex Pharmaceuticals Falls 3.1% in Regular Trading, Trading at $527.91

Market Focus
·
Sep 08

Aclaris, EyePoint, Vertex, GitLab, NioCorp Trending With Analysts

TIPRANKS
·
Sep 05

Vertex Pharmaceuticals Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 05

Vortex Energy to Launch Ground Gravity Survey at Robinsons River Salt Project

TIPRANKS
·
Sep 04

Vertex Minerals Seeks Trading Halt Ahead of Capital Raising Plan

TIPRANKS
·
Sep 03

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 03

Evercore ISI Adjusts Vertex Pharmaceuticals Price Target to $600 From $535, Maintains Outperform Rating

MT Newswires Live
·
Sep 02

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Alumis Inc. (ALMS) and Medtronic (MDT)

TIPRANKS
·
Sep 02

Vertex Pharmaceuticals Price Target Announced at $665.00/Share by Morgan Stanley

Dow Jones
·
Sep 02

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Sep 02

What Does Crinetics Pharmaceuticals (CRNX) Delisting Mean After The Takeover Closed?

Simply Wall St.
·
Sep 02

FedEx Incheon Gateway Wins IATA CEIV Pharma Certification

Reuters
·
Sep 02

Vertex Pharmaceuticals resumed with an Overweight at Morgan Stanley

TIPRANKS
·
Sep 02